|
Volumn 745, Issue 2, 2000, Pages 373-388
|
Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64- 0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine
a a a a b b c |
Author keywords
Oseltamivir; Ro 64 0802
|
Indexed keywords
4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID;
DICHLORVOS;
OSELTAMIVIR;
PRODRUG;
SIALIDASE INHIBITOR;
UNCLASSIFIED DRUG;
ACCURACY;
ARTICLE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DECOMPOSITION;
DRUG DETERMINATION;
DRUG HYDROLYSIS;
DRUG STABILITY;
DRUG URINE LEVEL;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A;
INFLUENZA VIRUS B;
MASS SPECTROMETRY;
NONHUMAN;
PLASMA;
PRIORITY JOURNAL;
RAT;
VALIDATION PROCESS;
ACETAMIDES;
ANIMALS;
ANTIVIRAL AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HUMANS;
INFLUENZA, HUMAN;
MASS SPECTROMETRY;
OSELTAMIVIR;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
|
EID: 0034682944
PISSN: 13872273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(00)00300-5 Document Type: Article |
Times cited : (99)
|
References (8)
|